Roivant Sciences (ROIV) Earnings Date, Estimates & Call Transcripts

$12.30

+0.11 (+0.90%)

(As of 09/6/2024 ET)

Upcoming Earnings Date: Nov. 11Estimated
Actual EPS (Aug. 8): $0.12 Beat By $0.33
Consensus EPS (Aug. 8): -$0.21

ROIV Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ROIV Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad WealthPress

This new buy indicator has the internet shook.

In the last few weeks we’ve seen countless people talking about a totally new stock indicator called Platform X… It identifies the markets strongest stocks, then delivers customized buy signals for those stocks… Even as the market stalled out it nailed several calls including a 100%+ winner on Newmont mining… At first we thought this was some sort of hocus pocus indicator… But it turned out to be a very viable tool for trading today’s market action… Which is the reason for today's email…

To check it out, just follow this link here.

Roivant Sciences Analyst EPS Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2024	1	($0.33)	($0.33)	($0.33)
Q2 2024	1	($0.33)	($0.33)	($0.33)
Q3 2024	1	($0.33)	($0.33)	($0.33)
Q4 2024	3	($0.39)	($0.20)	($0.31)
FY 2024	6	($1.38)	($1.19)	($1.30)
Q1 2025	2	($0.25)	($0.23)	($0.24)
Q2 2025	2	($0.33)	($0.25)	($0.29)
Q3 2025	2	($0.32)	($0.25)	($0.29)
Q4 2025	2	($0.26)	($0.26)	($0.26)
FY 2025	8	($1.16)	($0.99)	($1.08)
Q1 2026	1	($0.33)	($0.33)	($0.33)
Q2 2026	1	($0.33)	($0.33)	($0.33)
Q3 2026	1	($0.30)	($0.30)	($0.30)
Q4 2026	1	($0.30)	($0.30)	($0.30)
FY 2026	4	($1.26)	($1.26)	($1.26)

ROIV Earnings Date and Information

Roivant Sciences last announced its quarterly earnings results on August 8th, 2024. The reported $0.12 earnings per share for the quarter, beating the consensus estimate of ($0.21) by $0.33. The firm earned $55.10 million during the quarter, compared to analysts' expectations of $30.72 million. Its quarterly revenue was up 155.1% compared to the same quarter last year. Roivant Sciences has generated $5.06 earnings per share over the last year ($5.06 diluted earnings per share) and currently has a price-to-earnings ratio of 2.4. Earnings for Roivant Sciences are expected to grow in the coming year, from ($1.14) to ($1.12) per share. Roivant Sciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off prior year's report dates.

Roivant Sciences Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
11/11/2024 (Estimated)	-	-	-	-	-	-	-
8/8/2024	Q1 2025	($0.21)	$0.12	+$0.33	($0.60)	$30.72 million	$55.10 million
5/30/2024	Q4 2024	($0.31)	($0.28)	+$0.03	($0.37)	$32.46 million	$28.93 million
2/13/2024	Q3 2024	($0.33)	($0.26)	+$0.07	($6.55)	$30.72 million	$37.14 million
11/13/2023	Q2 2024	($0.35)	($0.33)	+$0.02	($0.26)	$26.68 million	$37.10 million
8/14/2023	Q2 2023	($0.28)	($0.38)	($0.10)	($0.38)	$24.49 million	$21.60 million
6/28/2023	Q4 2023	($0.41)	($0.20)	+$0.21	($0.35)	$18.94 million	$27.38 million
Get the Latest News and Ratings for ROIV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Roivant Sciences and its competitors with MarketBeat's FREE daily newsletter.
2/13/2023	Q3 2023	($0.36)	($0.49)	($0.13)	($0.49)	$14.29 million	$17.05 million
11/14/2022	Q2 2023	($0.41)	($0.42)	($0.01)	($0.42)	$6.71 million	$12.53 million
8/15/2022	Q1 2023	($0.30)	($0.48)	($0.18)	($0.48)	$6.45 million	$4.32 million
6/28/2022	Q4 2022	($0.25)	($0.39)	($0.14)	($0.39)	$11.94 million	$9.22 million
2/14/2022	Q3 2022	($0.23)	($0.41)	($0.18)	($0.41)	$10.13 million	$24.34 million
11/15/2021	Q2 2022	($1.06)	($0.87)	+$0.19	($1.42)	$5.30 million	$13.99 million
9/21/2021	Q1 2022	-	($0.37)	($0.37)	($0.37)	-	$7.74 million

Roivant Sciences Earnings - Frequently Asked Questions

When is Roivant Sciences's earnings date?: Roivant Sciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, November 11th, 2024 based off last year's report dates. Learn more on ROIV's earnings history.
Did Roivant Sciences beat their earnings estimates last quarter?: In the previous quarter, Roivant Sciences (NASDAQ:ROIV) reported $0.12 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.21) by $0.33. Learn more on analysts' earnings estimate vs. ROIV's actual earnings.
How can I listen to Roivant Sciences's earnings conference call?: The conference call for Roivant Sciences's latest earnings report can be listened to online. Listen to Conference Call
How can I read Roivant Sciences's conference call transcript?: The conference call transcript for Roivant Sciences's latest earnings report can be read online. Read Transcript
How much revenue does Roivant Sciences generate each year?: Roivant Sciences (NASDAQ:ROIV) has a recorded annual revenue of $158.30 million.
How much profit does Roivant Sciences generate each year?: Roivant Sciences (NASDAQ:ROIV) has a recorded net income of $4.35 billion. ROIV has generated $5.06 earnings per share over the last four quarters.
What is Roivant Sciences's price-to-earnings ratio?: Roivant Sciences (NASDAQ:ROIV) has a trailing price-to-earnings ratio of 2.43.
What is Roivant Sciences's EPS forecast for next year?: Roivant Sciences's earnings are expected to grow from ($1.14) per share to ($1.12) per share in the next year.